Chemotherapy as a double‐edged sword: Modulation of tumor‐associated cytokine and chemokine responses in ovarian cancer
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70132 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Amin Ullah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Targeting Therapy and Immunology, Cancer Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecula…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cytokines, Antineoplastic Agents, Chemokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 136 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Program, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Ovarian cancer (OC) is one of the most lethal gynecological malignancies, with high recurrence rates and chemoresistance posing significant challenges to effective treatment. Platinum‐based agents, such as cisplatin and carboplatin, along with taxanes, including paclitaxel and docetaxel, represent fundamental therapies for OC. However, the immunomodulatory effects of these agents on the tumor microenvironment are multifaceted and can be perceived as a double‐edged sword. Chemotherapeutics not only trigger cytotoxic effects but also influence the networks of pro‐ and anti‐tumor cytokines, playing a role in both treatment efficacy and resistance. We specifically examine cytokine‐mediated mechanisms underlying both platinum‐based and taxane‐based chemoresistance in OC. In this review, we comprehensively examine how platinum and taxane chemotherapy modulate cytokine signaling in OC, focusing on key mediators like interleukin (IL) 6, IL‐8, transforming growth factor‐beta, and C‐X‐C motif ligand 2 that drive survival pathways and chemoresistance. Interestingly, these agents might enhance anti‐tumor immunity via interferon‐gamma and IL‐12, revealing the potential for synergistic chemoimmunotherapy. This research provides valuable insights for addressing resistance and improving combination therapies through the analysis of the dual roles of chemotherapy in modulating cytokine dynamics in OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Targeting Therapy and Immunology, Cancer Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan,…
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China.
- Gynecology Department, Guangdong Women and Children Hospital, Guangzhou, China.
ORCID-Profile: Amin Ullah
Förderung
- Sichuan Province Science and Technology Program
- National Natural Science Foundation of China
Zitieren
APA
Ullah, A., Chen, Y., Shen, Y., & Shen, B. (2026). Chemotherapy as a double‐edged sword: Modulation of tumor‐associated cytokine and chemokine responses in ovarian cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.70132
Vancouver
Ullah A, Chen Y, Shen Y, Shen B. Chemotherapy as a double‐edged sword: Modulation of tumor‐associated cytokine and chemokine responses in ovarian cancer. International Journal of Cancer. 2026. doi:10.1002/ijc.70132
BibTeX
@article{Ullah2026,
author = {Ullah, Amin and Chen, Yongxiu and Shen, Yuan and Shen, Bairong},
title = {Chemotherapy as a double‐edged sword: Modulation of tumor‐associated cytokine and chemokine responses in ovarian cancer},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70132}
}
EUVIMED